Detalles de la búsqueda
1.
Mirabegron as Add-On Treatment to Solifenacin in Patients with Incontinent Overactive Bladder and an Inadequate Response to Solifenacin Monotherapy: Responder Analyses and Patient-Reported Outcomes from the BESIDE Study [corrected].
J Urol
; 196(3): 809-18, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27063854
2.
The influence of improved air quality on mortality risks in Erfurt, Germany.
Res Rep Health Eff Inst
; (137): 5-77; discussion 79-90, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19554968
3.
Source apportionment of ambient fine particle size distribution using positive matrix factorization in Erfurt, Germany.
Sci Total Environ
; 398(1-3): 133-44, 2008 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18433834
4.
Ambient source-specific particles are associated with prolonged repolarization and increased levels of inflammation in male coronary artery disease patients.
Mutat Res
; 621(1-2): 50-60, 2007 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17603085
5.
Treating Overactive Bladder in Older Patients with a Combination of Mirabegron and Solifenacin: A Prespecified Analysis from the BESIDE Study.
Eur Urol Focus
; 3(6): 629-638, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28916436
6.
An Exploratory Study in Healthy Male Subjects of the Mechanism of Mirabegron-Induced Cardiovascular Effects.
J Clin Pharmacol
; 57(12): 1534-1544, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28618007
7.
Can we identify sources of fine particles responsible for exercise-induced ischemia on days with elevated air pollution? The ULTRA study.
Environ Health Perspect
; 114(5): 655-60, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16675416
8.
Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE).
Eur Urol
; 70(1): 136-145, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26965560
9.
Workgroup report: workshop on source apportionment of particulate matter health effects--intercomparison of results and implications.
Environ Health Perspect
; 113(12): 1768-74, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16330361
10.
A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of the ß3 adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder.
Urology
; 82(2): 313-20, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23769122
11.
Short-term mortality rates during a decade of improved air quality in Erfurt, Germany.
Environ Health Perspect
; 117(3): 448-54, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19337521
12.
Semi volatile organic compounds in ambient PM2.5. Seasonal trends and daily resolved source contributions.
Environ Sci Technol
; 41(11): 3821-8, 2007 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17612155
13.
Daily mortality and particulate matter in different size classes in Erfurt, Germany.
J Expo Sci Environ Epidemiol
; 17(5): 458-67, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17108895
14.
PM source apportionment and health effects. 3. Investigation of inter-method variations in associations between estimated source contributions of PM2.5 and daily mortality in Phoenix, AZ.
J Expo Sci Environ Epidemiol
; 16(4): 311-20, 2006 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16288316
15.
PM source apportionment and health effects: 1. Intercomparison of source apportionment results.
J Expo Sci Environ Epidemiol
; 16(3): 275-86, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16249798
Resultados
1 -
15
de 15
1
Próxima >
>>